DSM in the news 2012
Biomaterials for ocular therapies advance comfort and utility
November 2012 – With the exception of the brain, the eye is the most complex organ in the human body. Eyes can process 36,000 bits of information every hour and contribute to 85% of a person’s total knowledge. It is not a surprise that ophthalmic technology is constantly evolving to generate treatments for eye diseases and innovative solutions for enhancing vision. As many ophthalmic disorders are a result of the aging process, ophthalmic products are growing in demand and biomaterials are playing a significant role in the advancement of many of these new ocular therapies.
Q&A: Polyurethanes offer long-term benefits in neurostimulation
October 2012 – In this Q&A, DSM Biomedical’s Chander Chawla talks with Medical Design about medical polyurethanes for long-term implantation of neurostimulator devices. He discusses the role these materials play as they help address both device efficacy and patient safety. Chawla is Business Manager, Polyurethanes, for Berkeley, CA-based DSM (dsm.com). More>
Cardiovascular Applications of Biomedical Materials
October 2012 – Every day, a healthy human heart pumps 2,000 gallons of blood through 60,000 miles of blood vessels. Given this demanding workload, it’s not surprising that people can suffer heart complications. People are living longer lives and the number of patients with cardiovascular disease is growing.
Resurgence For Medical Polymers
September 2012 - Polymer suppliers haven’t forgotten the bitter lessons that can come with the use of their materials in medical devices. They know all too well Dow Corning’s nine years in bankruptcy, which ended in 2004, and the $3.2 billion the firm agreed to pay to women who claimed that silicone breast implants made them ill. Today, however, polymer suppliers can count on the legal protections of the Biomaterials Access Assurance Act of 1998. More>
Hydrophilic Environments May Promote Easier Device Delivery
March 2012 - As minimally invasive technologies continue to permeate the healthcare industry, device makers need to ensure that their products make the process as smooth as possible. To this end, one solution offered to the OEMs focusing on device delivery is a hydrophilic coating that helps minimize resistance the catheter could face when traveling through the body.
Next-generation stabilization: Improving joint implant efficacy and durability
March 9, 2012 - Using hindered amine light stabilizer has long-term benefits for implants. HALS technology can be applied to total hip, knee, shoulder, and ankle implants, or any application in which stabilization of UHMWPE is needed. For years, metal-on-metal (MoM) bearings had been used for many orthopaedic joint reconstruction implants, particularly for total hip arthroplasty, which is one of the most common orthopaedic procedures. But new concerns about the biologic consequences of metal ion release from these bearings have emerged and are forcing the industry to explore alternative materials and technologies for this popular procedure. More>
Preventing protein build up on in-vivo devices and biosensors
February 2012 - Every day, medical technology advances enable the development of smaller devices and sensors that are able to continuously and instantly monitor a growing list of vital statistics and chemical compositions from inside the human body. These in-vivo devices have uses in surgical, diagnostic, and drug delivery applications across many medical and scientific practices. More>
Collaboration to yield novel transcatheter heart valves
February 2012 - DSM, a biomedical materials producer, and the University Medical Center Utrecht academic hospital, announced a collaboration agreement. DSM will contribute its Dyneema Purity fiber technology to enable UMC Utrecht to develop and evaluate a prototype of a non-biological supportive scaffold for the minimally invasive treatment of valvular and vascular diseases. More>
Norbert Sparrow, editor of European Medical Device Technology, interviews John Marugg, Business Manager of DSM Biomedical
February 2012 - EMDT Editor in Chief Norbert Sparrow interviews John Marugg, Business Manager at DSM Biomedical, about his company's collaboration with EPflex on the development of a new set of guidewires with a hydrophilic coating. More>